“…Recently, biopolymers have received immense consideration for biomedical applications. To this end, the use of bacterial cellulose (BC), produced by microbial cells ( Ullah et al, 2017 ) and cell-free systems ( Ullah et al, 2015 ; Kim et al, 2019 ), has received a growing interest as a biomaterial in various biomedical applications ( Klemm et al, 2001 ; Czaja et al, 2006 ; Khan et al, 2015a , b ; Hussain et al, 2019 ), specialty membrane ( Rajwade et al, 2015 ), biosensors ( Jasim et al, 2017 ; Farooq et al, 2020 ), and drug release ( Numata et al, 2015 ; Li et al, 2018 ). These applications utilize both pure BC and its composites with other materials, such as biopolymers including collagen ( Takeda et al, 2016 ), silk-sericin ( Lamboni et al, 2016 ), gelatin ( Khan et al, 2018 ), alginate ( Kirdponpattara et al, 2015 ), and chitosan ( Ul-Islam et al, 2019 ), and nanoparticles such as silver ( Maneerung et al, 2008 ), zinc ( Ul-Islam et al, 2014 ; Khalid et al, 2017a ), titanium dioxide ( Khan et al, 2015a , b ; Ullah et al, 2016a ; Khalid et al, 2017b ), and gold ( Khan et al, 2018 ), as well as clay materials such as pristine and modified montmorillonite ( Ul-Islam et al, 2013b ).…”